Tandem Capital Management Corp Abbott Laboratories Transaction History

Tandem Capital Management Corp

$169 Million
Q4 2024

A detailed history of Tandem Capital Management Corp transactions in Abbott Laboratories stock. As of the latest transaction made, Tandem Capital Management Corp holds 30,349 shares of ABT stock, worth $3.92 Million. This represents 2.03% of its overall portfolio holdings.

Number of Shares

30,349

Previous 31,069 2.32%

Holding current value

$3.92 Million

Previous $3.54 Million 3.11%

% of portfolio

2.03%

Previous 2.05%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 24, 2025	SELL	$111.93 - $119.39 $80,589 - $85,960	-720 Reduced 2.32%	30,349 $3.43 Million
Q3 2024 Oct 25, 2024	SELL	$100.07 - $118.13 $191,233 - $225,746	-1,911 Reduced 5.79%	31,069 $3.54 Million
Q3 2024 Oct 23, 2024	BUY	$100.07 - $118.13 $83,358 - $98,402	833 Added 2.59%	32,980 $3.76 Million
Q2 2024 Jul 08, 2024	SELL	$100.73 - $112.44 $83,908 - $93,662	-833 Reduced 2.53%	32,147 $3.34 Million
Q1 2024 May 16, 2024	BUY	$109.52 - $120.96 $4,490 - $4,959	41 Added 0.12%	32,980 $3.75 Million
Q4 2023 Feb 02, 2024	SELL	$90.19 - $110.4 $28,229 - $34,555	-313 Reduced 0.94%	32,939 $3.63 Million
Q3 2023 Oct 30, 2023	SELL	$95.53 - $114.62 $1,337 - $1,604	-14 Reduced 0.04%	33,252 $3.22 Million
Q2 2023 Aug 15, 2023	SELL	$100.78 - $112.29 $6,248 - $6,961	-62 Reduced 0.19%	33,266 $3.63 Million
Q1 2023 May 04, 2023	SELL	$96.86 - $114.01 $23,924 - $28,160	-247 Reduced 0.74%	33,328 $3.37 Million
Q4 2022 Jan 18, 2023	SELL	$95.06 - $111.52 $9,886 - $11,598	-104 Reduced 0.31%	33,575 $0
Q3 2022 Oct 24, 2022	BUY	$96.76 - $112.03 $78,569 - $90,968	812 Added 2.47%	33,679 $3.2 Million
Q2 2022 Jul 19, 2022	BUY	$102.07 - $123.37 $2,041 - $2,467	20 Added 0.06%	32,867 $3.57 Million
Q4 2021 Feb 04, 2022	BUY	$115.53 - $141.46 $6,354 - $7,780	55 Added 0.17%	32,847 $4.62 Million
Q3 2021 Oct 28, 2021	BUY	$116.66 - $129.06 $1,866 - $2,064	16 Added 0.05%	32,792 $3.87 Million
Q2 2021 Aug 06, 2021	SELL	$105.79 - $124.53 $19,359 - $22,788	-183 Reduced 0.56%	32,776 $3.8 Million
Q3 2020 Nov 03, 2020	SELL	$91.64 - $111.29 $36,656 - $44,516	-400 Reduced 1.2%	32,959 $3.59 Million
Q2 2020 Aug 13, 2020	SELL	$76.57 - $98.0 $287,520 - $367,990	-3,755 Reduced 10.12%	33,359 $3.05 Million
Q1 2020 May 12, 2020	SELL	$62.82 - $91.86 $197,254 - $288,440	-3,140 Reduced 7.8%	37,114 $2.93 Million
Q4 2019 Mar 04, 2020	BUY	$78.51 - $87.4 $3.16 Million - $3.52 Million	40,254 New	40,254 $3.5 Million

Others Institutions Holding ABT

# of Institutions

3,247

Shares Held

1.31B

Call Options Held

8.71M

Put Options Held

8.02M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $226B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Tandem Capital Management Corp , based on Form 13F filings with the SEC.

News

Stay updated on Tandem Capital Management Corp with notifications on news.

Account

Tandem Capital Management Corp Abbott Laboratories Transaction History